fluorescence. Mr M J requires 100 pg of dapsone on alternate days to control his rash. A small intestinal biopsy showed total villous atrophy and an elevated intra-epithelial cell lymphocyte count of 406 (normal below 200) . A serum sample taken on the same day as the gut biopsy was negative for ARA and other autoantibodies by conventional indirect immunofluorescence on normal rat tissue sections, but when retested on gliadin-treated rat tissue sections gave bright reticulin staining, confirming the presence of AGA with a titre of 1/200, and of IgG and IgA class.
Discussion
The case reported here illustrates the presence of circulating AGA in DH. In a recent study we screened sera from 55 adults with DH of whom 26 had been adhering to a strict GFD for at least two years (Unsworth, Leonard, Holborow & Fry, in preparation) . High titres of AGA were found only in patients treated solely with dapsone, and were closely related to the severity of the enteropathy. With only one exception, AGA were not found in patients on a strict GFD, even in low titre. In a previous study of children with untreated coeliac disease (Unsworth, Manuel et al. 1981) , and therefore a flat small intestinal mucosa, all cases were found to have high titres of serum AGA, which disappeared after commencement of a GFD, and reappeared on challenge. Hence screening sera for AGA promises to be a useful indicator of severe small intestinal villous atrophy in DH. A case of thyrotoxicosis presenting with choreoathetoid movements and a severe myopathy with bulbar involvement is described. Choreoathetosis has only occasionally been reported in thyrotoxicosis, and bulbar involvement in chronic thyrotoxic myopathy is rare. This case is unusual in presenting with both these complication which resolved completely after conventional drug treatment of the thyrotoxicosis.
References
Case report A 21-year-old man presented with a two month history of psychological disturbance, dysarthria, nasal regurgitation of fluids, generalized weakness, and involuntary movements. He also complained of thirst, polyuria, vomiting, heat intolerance, and had lost 15 kg in weight. There was no family history of thyroid disease or neurological disorder.
He was emaciated and unable to walk due to generalized muscle wasting. He had bulbar weakness, but no other features of myasthenia gravis, and choreoathetoid movements of his face and limbs, which were more severe on attention. There was a tachycardia of 100/min with hyperdynamic circulation, and moderate soft diffuse enlargement of the thyroid gland with a loud systolic bruit, lid retraction and lid lag, but no exophthalmos or ophthalmoplegia. All tendon reflexes were very brisk.
The following investigations were carried out: serum calcium 2.80 mmol/l (normal range 2.0-2.6), phosphate 1.63 mmol/l (normal range 0.8-1.4), bilirubin 11 smol/l, alkaline phosphatase 130 U/1, (normal range 30-92), gulamate pyruvate transaminase 64 U/1, (normal range 7-40), albumin 44 g/l, parathormone < 40 pg/ml (normal < 120), 25-hydroxy cholecalciferol 3.4 ng/ml (low normal); urinary calcium excretion 18.7 mmol/24 h (normal < 10) and urinary phosphate excretion 49.7 mmol/24 h (normal range 22-32). Serum thyroxine was > 300 nmol/l (normal range 55-144), triiodothyronine> 7.0 nmol/l (normal range 1.0-2.8) and antithyroid microsomal antibodies were positive in a titre of 1/100. Electromyography of the right deltoid muscle showed evidence of a myopathy, but microscopic examination of a biopsy of the left deltoid muscle revealed only mild fibre atrophy. A Tensilon test was negative. Computerized tomography of the brain was normal apart from minimal dilatation of the fourth ventricle.
Treatment was started with oral carbimazole, potassium iodide, and propranolol. Serum calcium increased to 3.22 mmol/l and serum phosphate fell to 0.88 mmol/l during the first nine days of treatment, but returned to normal within a week. There was rapid improvement in speech with a return of palatal movement, and increase in overall strength so that he was able to walk unaided within two weeks, and leave hospital one week later. At six weeks he was euthyroid and his abnormal movements had completely resolved.
Discussion
A severe chronic myopathy in assocation with thyrotoxicosis was first described by Bathurst in 1895. Bulbar involvement has subsequently been reported in this condition (Gaan 1967) but it is rare, and it is important to exclude myasthenia gravis.
Patients with an acute thyrotoxic myopathy, the main features of which were ptosis, dysarthria, dysphagia, nasal regurgitation of fluids, generalized weakness, and occasionally ophthalmoplegia, were described by several workers in the mid-1940s (Laurent 1944 , Waldenstrom 1945 , Sheldon & Walker 1946 . However, most of these cases were probably examples of myasthenia gravis complicating thyrotoxicosis, as the weakness was improved by neostigmine (Millikan & Haines 1953) . Acute thyrotoxic myopathy is therefore probably not a distinct entity but merely represents the stage, demonstrated by our patient, at which bulbar involvement complicates a chronic myopathy (Ramsay 1968 ).
An association between chorea and Graves' disease was first mentioned by Gowers in 1893 and we have found seven further reports in the English literature (Sutherland 1903 , Syner et al. 1945 , Heffron & Eaton 1970 , Fidler et al. 1971 , Dahr & Nair 1974 , Delwaide & Schoenen 1978 , Van Uitert & Russakoff 1979 . These were all young patients with severe thyrotoxicosis. A case of Huntington's chorea with thyrotoxicosis, in which the choreiform movements fluctuated in relation to the patient's thyroid status, has also been reported (Murthy et al. 1977) .
Hyperthyroid chorea is thought to be due, to increased sensitivity of striatal dopamine receptors to dopamine, associated with decreased cerebral dopamine turnover. Homovanillic acid levels in the cerebrospinal fluid, which are a direct reflection of dopamine metabolism within the central nervous system, are low in hyperthyroidism and high in hypothyroidism. In addition, the chorea of thyrotoxicosis is alleviated by haloperidol, a drug which blocks dopamine receptors. Experiments on hyperthyroid guinea pigs have demonstrated an increased responsiveness to dopaminergic stimulation of the striatum as measured by the dosage of apomorphine required to elicit stereotyped behaviour (Klawans et al. 1973) . These lines of evidence form the rationale behind the attempted use of L-dopa to detect presymptomatic cases of Huntington's chorea.
